Analysts Set The Clorox Company (NYSE:CLX) PT at $143.33

The Clorox Company (NYSE:CLX) has been given an average rating of “Reduce” by the seventeen research firms that are covering the stock, Marketbeat Ratings reports. Six research analysts have rated the stock with a sell recommendation and eleven have assigned a hold recommendation to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $143.33.

CLX has been the topic of several recent research reports. Wells Fargo & Company reduced their target price on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a report on Wednesday, July 10th. JPMorgan Chase & Co. lowered their price target on shares of Clorox from $150.00 to $148.00 and set a “neutral” rating for the company in a report on Friday, August 2nd. TD Cowen assumed coverage on shares of Clorox in a research report on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price objective on the stock. Argus upgraded shares of Clorox to a “hold” rating in a report on Tuesday, June 4th. Finally, BNP Paribas upgraded Clorox to a “strong sell” rating in a report on Friday, September 6th.

Insiders Place Their Bets

In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.51% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Core Wealth Advisors Inc. purchased a new stake in shares of Clorox in the fourth quarter worth $29,000. Innealta Capital LLC purchased a new stake in Clorox during the 2nd quarter valued at about $30,000. Trifecta Capital Advisors LLC increased its stake in Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after purchasing an additional 130 shares in the last quarter. GoalVest Advisory LLC purchased a new position in Clorox in the first quarter worth about $31,000. Finally, First Foundation Advisors bought a new position in shares of Clorox in the first quarter worth approximately $31,000. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Down 0.3 %

Shares of CLX stock opened at $162.90 on Tuesday. The business has a 50-day moving average price of $152.52 and a two-hundred day moving average price of $144.04. Clorox has a 12-month low of $114.68 and a 12-month high of $169.09. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The firm has a market cap of $20.23 billion, a P/E ratio of 84.40, a price-to-earnings-growth ratio of 3.31 and a beta of 0.40.

Clorox (NYSE:CLX) last released its earnings results on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The company had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. Equities analysts anticipate that Clorox will post 6.63 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.00%. Clorox’s dividend payout ratio (DPR) is currently 252.85%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.